Ezrin contributes to impaired podocyte migration and adhesion caused by advanced glycation end products

Nephrology

Volumn 21, Issue 1, 2016, Pages 13-20

  McRobert, Elizabeth Anne ^a   Bach, Leon A ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

cell adhesion; cell migration; diabetes; ezrin; glycation; podocyte

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BOVINE SERUM ALBUMIN; EZRIN; FIBRONECTIN; ADVANCED GLYCATION END PRODUCTS-BOVINE SERUM ALBUMIN; CYTOSKELETON PROTEIN;

ARTICLE; CELL ADHESION; CELL DAMAGE; CELL FUNCTION; CELL MEMBRANE; CELL MIGRATION; CELL SHAPE; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING; CELL LINE; CELL MOTION; CELL SURFACE; DIABETIC NEPHROPATHY; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TIME FACTOR;

CELL ADHESION; CELL LINE; CELL MOVEMENT; CELL SHAPE; CELL SURFACE EXTENSIONS; CYTOSKELETAL PROTEINS; DIABETIC NEPHROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRONECTINS; GENE EXPRESSION REGULATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; PODOCYTES; SERUM ALBUMIN, BOVINE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 84951778548     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12526     Document Type: Article

References (34)

1. Forbes JM, Cooper ME,. Mechanisms of diabetic complications. Physiol. Rev. 2013; 93: 137-188.
2. Welsh GI, Hale LJ, Eremina V, et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab. 2010; 12: 329-340.
3. Dai C, Stolz DB, Bastacky SI, et al. Essential role of integrin-linked kinase in podocyte biology: Bridging the integrin and slit diaphragm signaling. J. Am. Soc. Nephrol. 2006; 17: 2164-2175.
4. Arpin M, Chirivino D, Naba A, Zwaenepoel I,. Emerging role for ERM proteins in cell adhesion and migration. Cell Adh. Migr. 2011; 5: 199-206.
5. Takeda T, McQuistan T, Orlando RA, Farquhar MG,. Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. J. Clin. Invest. 2001; 108: 289-301.
6. Ostalska-Nowicka D, Zachwieja J, Nowicki M, Kaczmarek E, Siwinska A, Witt M,. Ezrin-a useful factor in the prognosis of nephrotic syndrome in children: An immunohistochemical approach. J. Clin. Pathol. 2006; 59: 916-920.
7. McRobert EA, Gallicchio M, Jerums G, Cooper ME, Bach LA,. The amino-terminal domains of the ezrin, radixin, and moesin (ERM) proteins bind advanced glycation end products, an interaction that may play a role in the development of diabetic complications. J. Biol. Chem. 2003; 278: 25783-25789.
8. Gallicchio MA, McRobert EA, Tikoo A, Cooper ME, Bach LA,. Advanced glycation end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent manner. J. Am. Soc. Nephrol. 2006; 17: 414-421.
9. McRobert EA, Young AN, Bach LA,. Advanced glycation end-products induce calpain-mediated degradation of ezrin. FEBS J. 2012; 279: 3240-3250.
10. McRobert EA, Tikoo A, Cooper ME, Bach LA,. Localization of the ezrin binding epitope for advanced glycation endproducts. Int. J. Biochem. Cell Biol. 2008; 40: 1570-1580.
11. Saleem MA, O'Hare MJ, Reiser J, et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J. Am. Soc. Nephrol. 2002; 13: 630-638.
12. Amieva MR, Litman P, Huang L, Ichimaru E, Furthmayr H,. Disruption of dynamic cell surface architecture of NIH3T3 fibroblasts by the N-terminal domains of moesin and ezrin: In vivo imaging with GFP fusion proteins. J. Cell Sci. 1999; 112: 111-125.
13. Thomas MC, Forbes JM, Cooper ME,. Advanced glycation end products and diabetic nephropathy. Am. J. Ther. 2005; 12: 562-572.
14. Wendt T, Tanji N, Guo J, et al. Glucose, gycation, and RAGE: Implications for amplification of cellular dysfunction in diabetic nephropathy. J. Am. Soc. Nephrol. 2003; 14: 1383-1395.
15. Wasik AA, Koskelainen S, Hyvonen ME, et al. Ezrin is down-regulated in diabetic kidney glomeruli and regulates actin reorganization and glucose uptake via GLUT1 in cultured podocytes. Am. J. Pathol. 2014; 184: 1727-1739.
16. Ruster C, Bondeva T, Franke S, Forster M, Wolf G,. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes. Nephrol. Dial. Transplant. 2008; 23: 2179-2191.
17. Giardino I, Edelstein D, Brownlee M,. Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. J. Clin. Invest. 1994; 94: 110-117.
18. Fukami K, Yamagishi S, Kaifu K, et al. Telmisartan inhibits AGE-induced podocyte damage and detachment. Microvasc. Res. 2013; 88: 79-83.
19. Orlando RA, Takeda T, Zak B, et al. The glomerular epithelial cell anti-adhesin podocalyxin associates with the actin cytoskeleton through interactions with ezrin. J. Am. Soc. Nephrol. 2001; 12: 1589-1598.
20. Schmieder S, Nagai M, Orlando RA, Takeda T, Farquhar MG,. Podocalyxin activates rhoa and induces actin reorganization through NHERF1 and Ezrin in MDCK cells. J. Am. Soc. Nephrol. 2004; 15: 2289-2298.
21. Pierchala BA, Munoz MR, Tsui CC,. Proteomic analysis of the slit diaphragm complex: CLIC5 is a protein critical for podocyte morphology and function. Kidney Int. 2010; 78: 868-882.
22. Wegner B, Al-Momany A, Kulak SC, et al. CLIC5A, a component of the ezrin-podocalyxin complex in glomeruli, is a determinant of podocyte integrity. Am. J. Physiol. Renal Physiol. 2010; 298: F1492-1503.
23. Adada M, Canals D, Hannun YA, Obeid LM,. Sphingolipid regulation of ezrin, radixin, and moesin proteins family: Implications for cell dynamics. Biochim. Biophys. Acta 2013; 13: 140-146.
24. Jiang L, Phang JM, Yu J, et al. CLIC proteins, ezrin, radixin, moesin and the coupling of membranes to the actin cytoskeleton: A smoking gun? Biochim. Biophys. Acta 2014; 1838: 643-657.
25. Lopez JP, Turner JR, Philipson LH,. Glucose-induced ERM protein activation and translocation regulates insulin secretion. Am. J. Physiol. Endocrinol. Metab. 2010; 299: E772-785.
26. Charrin S, Alcover A,. Role of ERM (ezrin-radixin-moesin) proteins in T lymphocyte polarization, immune synapse formation and in T cell receptor-mediated signaling. Front. Biosci. 2006; 11: 1987-1997.
27. Crepaldi T, Gautreau A, Comoglio PM, Louvard D, Arpin M,. Ezrin is an effector of HGF-mediated migration and morphogenesis in epithelial cells. J. Cell Biol. 1997; 138: 423-434.
28. Stitt-Cavanagh E, MacLeod L, Kennedy C,. The podocyte in diabetic kidney disease. ScientificWorldJournal 2009; 9: 1127-1139.
29. Lewko B, Stepinski J,. Hyperglycemia and mechanical stress: Targeting the renal podocyte. J. Cell. Physiol. 2009; 221: 288-295.
30. Tanji N, Markowitz GS, Fu C, et al. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J. Am. Soc. Nephrol. 2000; 11: 1656-1666.
31. Buckley ST, Medina C, Kasper M, Ehrhardt C,. Interplay between RAGE, CD44, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011; 300: L548-559.
32. Thallas-Bonke V, Thorpe SR, Coughlan MT, et al. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes 2008; 57: 460-469.
33. Paclet MH, Berthier S, Kuhn L, Garin J, Morel F,. Regulation of phagocyte NADPH oxidase activity: Identification of two cytochrome b558 activation states. FASEB J. 2007; 21: 1244-1255.
34. Corcoran A, Cotter TG,. FLT3-driven redox-modulation of Ezrin regulates leukaemic cell migration. Free Radic. Res. 2013; 47: 20-34.